USPTO serial 88013089
R X +
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LINDEMYER, ANKHI MUKHERJEA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with R X +?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Chuo-ku, Tokyo, JP
Chuo-ku, Tokyo, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christian S. Morgan
Christian S. Morgan Baker & McKenzie LLP300 E. Randolph StreetSuite 5000Chicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable medical software for processing and displaying images on ultrasound medical imaging machines, downloadable computer software for controlling and managing patient medical information, downloadable medical software for processing and displaying affected part images on medical resonance imaging machines (MRIs), downloadable software for medical imaging equipment, namely, for interpreting the results of CT scanners, downloadable computer programs for use in the operation of medical ultrasound detectors, computer software for medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct and for conducting medical diagnostic testing | ACTIVE | — |
| 042 | Providing temporary use of on-line non-downloadable computer programs for use in medical examination for the treatment of type2 diabetes mellitus, metabolic syndrome, bladder disorder, gastroesophageal reflex disease, fecal incontinence, glaucoma, cancer, cognitive impairment associated with schizophrenia, ophthalmology, arrhythmia and bile duct, research and development services in the field of scientific or medical field, providing scientific research information in the field of clinical trials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 10, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 10, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 8, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 7, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Sep 1, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Sep 1, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 3, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 3, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 3, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 3, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 12, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 10, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 10, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 10, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 21, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 20, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 17, 2021 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Sep 17, 2021 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Sep 17, 2021 | PETG | PETITION TO REVIVE-GRANTED | — |
| Sep 17, 2021 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Sep 10, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 23, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 19, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 19, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 19, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 13, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 14, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 12, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 12, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 12, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 10, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 14, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 25, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 9, 2019 | ALIE | ASSIGNED TO LIE | — |
| Dec 6, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 6, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 6, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 6, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 6, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 17, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 17, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 17, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 12, 2019 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jun 12, 2019 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jun 12, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 22, 2019 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Apr 22, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 22, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 22, 2019 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 23, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2018 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 29, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 28, 2018 | NWAP | NEW APPLICATION ENTERED | — |